Home   >  
Cell Cycle/DNA Damage
  >  
PPAR

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

PPAR

Chemical Structure Cat. No. Product Name CAS No.
GW6471 Chemical Structure
BCP35208 GW6471 880635-03-0
GW 6471 is a potent PPARα antagonist.
LY518674 Chemical Structure
BCP34904 LY518674 425671-29-0
LY518674 is a potent, selective PPARα antagonist, with an EC50 of 42 nM for human PPARα. LY518674 reduces triglycerides in and increased HDL-C and is used for the treatment of atherosclerosis.
GW6471 Chemical Structure
BCP33242 GW6471 436159-64-7
GW6471 is a potent PPARα antagonist.
Sipoglitazar Chemical Structure
BCP33099 Sipoglitazar 342026-92-0
Sipoglitazar is a dual peroxisome proliferator-activated receptor (PPAR) alpha and gamma agonist, with hypoglycemic activity.
Tesaglitazar Chemical Structure
BCP23582 Tesaglitazar 251565-85-2
Tesaglitazar is a PPAR agonist potentially for the treatment of type 2 diabetes. The drug had completed several phase III clinical trials, however in May, 2006 AstraZeneca announced that it had discontinued further development.
Pioditazone hydrochloride Chemical Structure
BCP22942 Pioditazone hydrochloride 112529-15-4
Pioglitazone hydrochloride is a potent and selective PPARγ agonist with EC50s of 0.93 and 0.99 μM for human and mouse PPARγ, respectively.
MK 0767 Chemical Structure
BCP30796 MK 0767 934017-32-0
MK 0767 is a dual peroxisome proliferator-activated receptor (PPAR) alpha/gamma agonist, has been studied as a potential treatment of type 2 diabetes and dyslipidemia.
MA-0204 Chemical Structure
BCP30365 MA-0204 2095128-17-7
MA-0204 is a potent, highly selective and orally available peroxisome proliferator activated receptor δ (PPARδ) modulator with EC50s of 0.4 nM, 7.9 nM and 10 nM for human, mouse and rat PPARδ, respectively. Potential treatment for Duchene Muscular Dystrophy (DMD).
Darglitazone Chemical Structure
BCP30326 Darglitazone 141200-24-0
Darglitazone is an agent belonging to the glitazone class of antidiabetic agents with antihyperglycemic and anti-inflammatory activities. Darglitazone may be able to abrogate acute cerebral inflammatory responses via its suppression of proinflammatory gene expression.
Choline Fenofibrate Chemical Structure
BCP28592 Choline Fenofibrate 856676-23-8
Choline Fenofibrate (ABT-335) is the choline salt of fenofibric acid under clinical development as a combination therapy with rosuvastatin for the management of dyslipidemia.
123下一頁末頁共 47 條記錄 1 / 5 頁 
0086-13720134139
福建36选7奖金 百人牛牛鱼丸游戏下载 海南4开奖结 排列五走势图分析 球探网即时比分手机 莱特币交易平台okcoin 江苏11选5在线投注 2021狗狗币价格 psp成都麻将 长沙麻将的算法 竞猜足球总奖金怎么算 比分直播网 比特币挖矿机托管 全民麻将4399小游戏 黑龙江时时彩查询 排列5专家预测 网赌一分钟赛车